Company intelligence / Profile preview

Cordis

Miami Lakes, Florida, United Statescordis.com ↗

Ownership: Private
Employees: ~3706
Development stage: Commercial

Overview

Cordis develops and markets a broad portfolio of medical devices for diagnostics and interventional procedures in coronary and peripheral vascular diseases. It has pioneered several innovations such as the first sheath introducers with hemostasis valves and drug-eluting stents. Recent clinical milestones include FDA premarket approval for the Mynx Control venous vascular closure device in 2024[8].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

1 asset

SELUTION SLR

Commercial

Indications: Peripheral artery disease, Coronary artery disease

Partnerships

CordisX innovation incubatorstrategic agreements to expand cardiology offerings in China

Beyond the preview

Go deeper on Cordis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cordis.

Explore the full profile